Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The U.S. Food and Drug Administration has prohibited Ranbaxy Laboratories in Toansa, India, from manufacturing and distributing active pharmaceutical ingredients for FDA-regulated drug products.
The clinical trials new drugs and devices must undergo for approval by the U.S. Food and Drug Administration hold the drugs to varying degrees of approval, according to a study published in the Journal of the American Medical Association.
Baptist Health and Norton Healthcare, both based in Louisville, Ky., have entered a five-year joint purchasing agreement with Mundelein, Ill.-based Medline, according to a news release.
Purchased services agreements present an area of potential savings for operational budgets if hospitals have the tools to control and reprioritize their purchased services spending.
The FDA recently approved sofosbuvir as a once-daily oral treatment for hepatitis C, according to a Gastroenterology & Endoscopy News report.
The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic's CoreValve Transcatheter for use without undergoing an independent device advisory panel review for the product, according to a Medtronic news release.
A Markets and Markets report projects the portable medical device market to be valued at $20 billion by 2018, according to a news release.
The U.S. Food and Drug Administration has cleared Irvine (Calif.) Biomedical to market its Therapy Cool Flex Ablation Catheter as a treatment for typical atrial flutter.
The U.S. Food and Drug Administration has issued draft guidance regarding the implementation of the custom device exception in the Food, Drug and Cosmetic Act.
The market for medical device outsourcing and contract manufacturers as brand owners is expected to increase to more than $12 billion by 2018.